Founded in 2018, IamFluidics is based on discoveries developed at the departments of Developmental BioEngineering and Physics of Fluids of the University of Twente. Its proprietary technology enables the manipulation of liquids in the air, called in-air microfluidics. In-air microfluidics technology enables production rates of up to 1,000 times the rate of existing chip-based technologies. Additional benefits are that the expensive microfluidic chips are no longer required and it creates new 3D printing possibilities such as 3D printing of living cells.
Microparticles are used in many advanced materials and composites, in industries such as personal care, healthcare, and the chemical industry. For example, microparticles are used in the healthcare industry as contrast agents in contrast-enhanced ultrasound or MRI procedures.
The technology of IamFluidics will enable a wide-spread industrial and clinical application of microfluidics, as its technology offers production of up to 1,000 times more than existing chip-based technologies while having the same consistency in shape and size. As a result, it will now become economically feasible to use microparticles in many more applications than the existing ones.